Show simple item record

dc.contributor.authorRashtchizadeh, N
dc.contributor.authorKarimi, P
dc.contributor.authorDehgan, P
dc.contributor.authorSalimi Movahed, M
dc.date.accessioned2018-08-26T05:41:44Z
dc.date.available2018-08-26T05:41:44Z
dc.date.issued2015
dc.identifier10.15171/jcvtr.2015.23
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/40539
dc.description.abstractThis study aimed to discover by which mechanism selenium (Se) suppresses stimulated platelets stimulation in oxidative stress underlying diseases.Human platelets pretreated with Se and stimulated by Cu(2+)-oxidized low density of lipoprotein (OxLDL) or thrombin before assessment of P-selectin and phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK), phosphorylated Jun N-terminal kinase (p- JNK), and phosphorylated extracellular signal-regulated kinases (p-ERK1/2). All variables were measured by solid phase sandwich enzyme-linked immunosorbent assay (ELISA).Se significantly decreased Cu(2+)-OxLDL induced P-selectin expression, as well as p38 and JNK phosphorylation in platelets, but could not significantly reduce ERK1/2 phosphorylation.Se suppresses inflamed platelets. This effect maybe partly mediated by the p38 or c-JNK signaling pathways. These results create possibility of new co-anti-inflammatory insight for Se in atherosclerosis.
dc.language.isoEnglish
dc.relation.ispartofJournal of cardiovascular and thoracic research
dc.titleEffects of Selenium in the MAPK Signaling Cascade.
dc.typearticle
dc.citation.volume7
dc.citation.issue3
dc.citation.spage107
dc.citation.epage12
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.15171/jcvtr.2015.23


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record